搜索临床试验以:TC-5214
总计388个结果
-
Astellas Pharma Inc完全的
-
Enanta Pharmaceuticals, IncPharmaceutical Research Associates完全的
-
Chinese University of Hong KongNorth District Hospital; King Chulalongkorn Memorial Hospital; Changi General Hospital完全的
-
Lawson Health Research InstituteThe Ottawa Hospital完全的
-
Yazeed Sawalha撤销复发性 1 级滤泡性淋巴瘤 | 复发性 2 级滤泡性淋巴瘤 | 复发性套细胞淋巴瘤 | 复发性边缘区淋巴瘤 | 难治性 B 细胞非霍奇金淋巴瘤 | 复发性 B 细胞非霍奇金淋巴瘤 | 复发性 3a 级滤泡性淋巴瘤 | 难治性 1 级滤泡性淋巴瘤 | 难治性 2 级滤泡性淋巴瘤 | 难治性 3a 级滤泡性淋巴瘤 | 难治性套细胞淋巴瘤 | 复发性滤泡性淋巴瘤 | 难治性滤泡性淋巴瘤 | 难治性边缘区淋巴瘤 | 复发性华氏巨球蛋白血症 | 难治性华氏巨球蛋白血症 | 复发性淋巴浆细胞性淋巴瘤 | 难治性淋巴浆细胞性淋巴瘤 | 粘膜相关淋巴组织的复发性结外边缘区淋巴瘤 | 粘膜相关淋巴组织难治性结外边缘区淋巴瘤 | 难治性淋巴结边缘区淋巴瘤 | 复发性淋巴结边缘区淋巴瘤 | 复发性脾边缘区淋巴瘤 | 难治性脾边缘区淋巴瘤
-
University of VirginiaAmerican Cancer Society, Inc.撤销
-
Parker Institute for Cancer ImmunotherapyBristol-Myers Squibb; Cancer Research Institute, New York City; Celldex Therapeutics; Oncovir, Inc. 和其他合作者完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人
-
McGill University Health Centre/Research Institute...ASGE完全的
-
Comprehensive Support Project for Oncology Research完全的
-
AgendiaUniversity of South Florida; University of Miami; University of Oklahoma; Ohio State University... 和其他合作者完全的
-
Eben RosenthalNational Cancer Institute (NCI)完全的
-
Cancer Research UK终止
-
Clatterbridge Centre for Oncology未知淋巴瘤 | 小肠癌 | 中性粒细胞减少症 | 脑和中枢神经系统肿瘤 | 未明确的成人实体瘤,特定方案 | 癌症的社会心理影响及其治疗英国
-
Nektar Therapeutics终止
-
Peking Union Medical College Hospital完全的
-
St. Jude Children's Research HospitalAssisi Foundation完全的
-
Fudan University未知
-
University Hospital, Clermont-Ferrand完全的
-
Fudan UniversityShanxi Province Cancer Hospital; Jiangxi Provincial Cancer Hospital; Jiangsu Cancer Institute... 和其他合作者完全的
-
AGO Study GroupGERCOR - Multidisciplinary Oncology Cooperative Group; Nordic Society of Gynaecological Oncology...完全的
-
Mitsubishi Tanabe Pharma Corporation完全的
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; AIDS Clinical Trials Group; SAb Biotherapeutics... 和其他合作者完全的
-
University of WashingtonNational Cancer Institute (NCI); AstraZeneca完全的
-
National Cancer Institute (NCI)招聘中复发性滤泡性淋巴瘤 | 难治性滤泡性淋巴瘤 | 1 级滤泡性淋巴瘤 | 2 级滤泡性淋巴瘤 | 3a 级滤泡性淋巴瘤美国